摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[[(2S)-pyrrolidin-2-yl]methyl]pyrimidin-2-amine | 1187303-81-6

中文名称
——
中文别名
——
英文名称
N-[[(2S)-pyrrolidin-2-yl]methyl]pyrimidin-2-amine
英文别名
——
N-[[(2S)-pyrrolidin-2-yl]methyl]pyrimidin-2-amine化学式
CAS
1187303-81-6
化学式
C9H14N4
mdl
——
分子量
178.237
InChiKey
GQWUHDKWAWDPPC-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    49.8
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    参考文献:
    名称:
    From lead to preclinical candidate: Optimization of β-homophenylalanine based inhibitors of dipeptidyl peptidase IV
    摘要:
    A series of highly potent and selective inhibitors of DPP-4 was optimized for ADMET properties. The effort resulted in the discovery of inhibitor 1g, that exhibits excellent efficacy in an oral glucose tolerance test and an attractive pharmacokinetic profile. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.06.036
  • 作为产物:
    描述:
    tert-butyl (2S)-2-[(pyrimidin-2-ylamino)methyl]pyrrolidine-1-carboxylate 在 三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 生成 N-[[(2S)-pyrrolidin-2-yl]methyl]pyrimidin-2-amine
    参考文献:
    名称:
    From lead to preclinical candidate: Optimization of β-homophenylalanine based inhibitors of dipeptidyl peptidase IV
    摘要:
    A series of highly potent and selective inhibitors of DPP-4 was optimized for ADMET properties. The effort resulted in the discovery of inhibitor 1g, that exhibits excellent efficacy in an oral glucose tolerance test and an attractive pharmacokinetic profile. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.06.036
点击查看最新优质反应信息

文献信息

  • From lead to preclinical candidate: Optimization of β-homophenylalanine based inhibitors of dipeptidyl peptidase IV
    作者:Sonja Nordhoff、Meritxell López-Canet、Barbara Hoffmann-Enger、Stephan Bulat、Silvia Cerezo-Gálvez、Oliver Hill、Claudia Rosenbaum、Christian Rummey、Meinolf Thiemann、Victor G. Matassa、Paul J. Edwards、Achim Feurer
    DOI:10.1016/j.bmcl.2009.06.036
    日期:2009.8
    A series of highly potent and selective inhibitors of DPP-4 was optimized for ADMET properties. The effort resulted in the discovery of inhibitor 1g, that exhibits excellent efficacy in an oral glucose tolerance test and an attractive pharmacokinetic profile. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多